Clinical study of photodynamic therapy for peripheral typelung cancers

Clinical study of photodynamic therapy for peripheral typelung cancers - Clinical study of photodynamic therapy for peripheral typelung cancers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021501

Enrollment

Registered

2016-03-16

Start date

2016-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Photodynamic theapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cancer nodule within 20mm in maximum measured by thin-slice CT Negative for lymphnode or distant metastasis measured by FDG-PET, abdomnal CT or US, Brain CT or MRI. ECOG PS 0-2 Over 20 years old Platete: 100000~400000 PT-INR: less than 1.4 Diagnosed as non-small cell lung cancer by trans-bronchal biopsy or cytology Inoperable case or Reject operation cases with written informed concent

Exclusion criteria

Exclusion criteria: Patients with anti-coagulant dose, except for salicylic acid formulation in the past week women who are/may pregnant, or lactating Patients with serious complications such as heart disease, liver disease and kidney failure Patients who have the porphyria Patients who have the sunlight hypersensitivity Patients who have been determined to be inappropriate as a subject upon the doctor's discretion

Design outcomes

Primary

Measure	Time frame
frequency of adverse event of grade 2 or more within 90 days of PDT	—

Secondary

Measure	Time frame
Recurrence free survival rate at 90days and 1 year after PDT	—

Countries

Japan

Contacts

Public ContactJitsuo Usuda

Nippon Medical School Hospital Thoracic Surgery

jusuda@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026